Conference Description

Emerging Challenges in Primary Care: 2007

November 10-11, 2007
Crowne Plaza Tampa East
10221 Princess Palm Avenue
Tampa, FL
813-623-6363

Tell a friend about this conference

Download the brochure for this conference

CME Credits: 10.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:

This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis. This program will incorporate didactic lectures, case based learning, and utilize an audience response system to facilitate discussion among participants to enhance the educational opportunity.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. appreciate that given its favorable risk to benefit ratio, the more widespread and appropriate aggressive management of patients with statins will confer statistically significant and clinically important reductions in myocardial infarction, stroke, and deaths from cardiovascular disease
2. review early pathogenesis and prevention of type 2 diabetes, more effectively attain tight glucose control and discuss recent outcomes trials on the development and progression of atherosclerosis in diabetes
3. review glycemic and cardiovascular outcomes from insulin trials in type 2 diabetes, and optimize glycemic control with insulin in type 2 diabetes while minimizing weight gain and hypoglycemia
4. understand the role of immune response modifiers in the treatment of warts; appreciate the mechanisms of action and efficacy of anti-inflammatory dose doxycycline in acne rosacea, and learn appropriate use of topical steroids and calcipotriene for the treatment of psoriasis
5. identify the risk factors for Insomnia, understand the principles of sleep restriction, and more appro - priately utilize currently available hypnotic therapies
6. utilize diagnostic criteria for Restless Leg Syndrome, understand recent advances in the pathophysiology of the disease, utilize current behavioral and phar - ma cologic treatment options to reduce symptoms and increase quality of life
7. more quickly and effectively recognize and diagnose cognitively impaired patients with increased understanding of the pathology of dementia and evolving treatment strategies
8. critically evaluate the evidence behind diagnostic and therapeutic options for constipation predominant irritable bowel syndrome and chronic constipation
9. recognize the underlying pathophysiology of BPH, utilize the AUA scoring system and choose appropriate pharmacotherapy and surgical inter - ventions for BPH
10. identify the most pertinent adverse events seen in the Women’s Health Initiative and advise patients on the risks and benefits of traditional, non-traditional, and alternative medical interventions for addressing menopausal symptoms

Agenda:
Saturday, November 10, 2007

7:15-7:50 am		Registration, Continental Breakfast and Welcome
7:50-8:10		Welcome Remarks and Pre-Assessment Gregg Sherman, MD
8:10-9:10		Update on Statins in the Treatment and Prevention of Cardiovascular Disease: Clinical and Public Health Challenges Charles Hennekens, MD, DrPH
9:10-10:10		Fundamentals of Quality Diabetes Care Patrick Boyle, MD
10:10-10:30		Break
10:30-11:30		Insulin Therapy in Type 2 Diabetes – Who, When, and How Patrick Boyle, MD
11:30-12:30		Dermatology Therapy Update: Warts, Rosacea and Psoriasis Deborah Zell, MD
12:30-1:30		Lunch
1:30-2:30		Insomnia: Who Gets It, and What Can be Done About It? Barbara Phillips, MD
2:30-3:30		Update on Restless Leg Syndrome Barbara Phillips, MD
3:30-3:50		Break
3:50-4:50		Alzheimer’s Disease: Evaluation, Staging and Treatment in Primary Care Walter Martinez, MD

Sunday, November 11, 2007

Faculty:
Patrick J. Boyle, MD
Professor of Medicine
University of New Mexico
Albuquerque, NM

Kenneth R. DeVault, MD
Professor of Medicine
Chair, Division of Gastroenterology and Hepatology
Mayo Clinic College of Medicine, Jacksonville, FL

Charles Hennekens, MD, DrPH
Sir Richard Doll Research Professor of Biomedical Science,
Center of Excellence, Florida Atlantic University
Voluntary Professor of Medicine & Epidemiology
and Public Health,
University of Miami Miller School of Medicine
Clinical Professor of Preventive Medicine,
NOVA Southeastern University, Boca Raton, FL

Louis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health & Family Medicine
University of Florida
Gainseville, FL

Walter C. Martinez, MD, FAAN
Director Memory Disorder Center
Director Premiere Research Institute
Associate Clinical Professor of Neurology at Nova Southeastern University
Fort Lauderdale, FL

Barbara Phillips, MD, MSPH, FCCP
Professor of Medicine, Division of Pulmonary,
Critical Care and Sleep Medicine
University of KY College of Medicine

Deborah Simon Zell, MD
Department of Dermatology and Cutaneous Surgery
Miller School of Medicine, University of Miami
Miami, FL

Program Chair: Gregg Sherman, MD

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 10 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this continuing medical education activity for a maximum of 10 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This offering meets the requirements for 10 contact hours for nurses, as specified by the Massachusetts Board of Registration in Nursing (244- CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidenced- based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

This program was supported through educational grants from the following companies: Amylin, AstraZeneca, Bayer, Boehringer- Ingelheim, Collagenex, Eisai, Merck, NovoNordisk, Sanofi Aventis, Takeda Pharmaceuticals North America, Wyeth.

REGISTRATION FOR THIS PROGRAM IS CLOSED.